Role of Phytoestrogens in Endometriosis

This narrative review evaluates recent studies exploring the biological activity of phytoestrogens—specifically isoflavones, stilbenes, flavonoids, and curcuminoids—in relation to endometriosis pathophysiology. Emphasis was placed on their effects on estrogen signaling, inflammation, angiogenesis, oxidative stress, and apoptosis.

Phytoestrogens exhibit both estrogenic and anti-estrogenic properties depending on their concentration and receptor affinity. Compounds such as resveratrol, genistein, and quercetin have demonstrated the ability to inhibit aromatase activity, downregulate pro-inflammatory cytokines (e.g., TNF-α, IL-6, and COX-2), and suppress vascular endothelial growth factor (VEGF) expression. These actions contribute to reduced lesion growth, decreased inflammation, and enhanced apoptosis in experimental models. Despite these promising findings, clinical data remain limited, and bioavailability concerns, individual variability in metabolism, and potential adverse effects—such as gastrointestinal discomfort or endocrine disruption—must be carefully considered.

Phytoestrogens represent promising adjuncts in the treatment of endometriosis due to their multi-targeted molecular actions and relatively favorable safety profile. However, their clinical application requires further validation through randomized controlled trials. Specialist supervision is recommended to ensure optimal dosing, monitor safety, and evaluate interactions with standard hormonal therapies. Disclosure The authors have nothing to report. Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

- 1G. F. Meresman, M. Götte, and M. W. Laschke, “Plants as Source of New Therapies for Endometriosis: A Review of Preclinical and Clinical Studies,” Human Reproduction Update 27, no. 2 (2021): 367–392. - 2K. T. Zondervan, C. M. Becker, and S. A. Missmer, “Endometriosis,” New England Journal of Medicine 382, no. 13 (2020): 1244–1256. - 3B. Smolarz, K. Szyłło, and H. Romanowicz, “Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature),” International Journal of Molecular Sciences 22, no. 19 (2021): 10554. - 4M. Ruszała, D. F. Dłuski, I. Winkler, J. Kotarski, T. Rechberger, and M. Gogacz, “The State of Health and the Quality of Life in Women Suffering From Endometriosis,” Journal of Clinical Medicine 11, no. 7 (2022): 2059. - 5G. Halis and A. Arici, “Endometriosis and Inflammation in Infertility,” Annals of the New York Academy of Sciences 1034 (2004): 300–315. - 6C. L. Bendon and C. M. Becker, “Potential Mechanisms of Postmenopausal Endometriosis,” Maturitas 72, no. 3 (2012): 214–219. - 7H. Zhao, L. Zhou, A. J. Shangguan, and S. E. Bulun, “Aromatase Expression and Regulation in Breast and Endometrial Cancer,” Journal of Molecular Endocrinology 57, no. 1 (2016): R19–R33. - 8S. E. Bulun, B. D. Yilmaz, C. Sison, et al., “Endometriosis,” Endocrine Reviews 40, no. 4 (2019): 1048–1079. - 9U. R. Budihastuti, D. Dasuki, A. H. Sadewa, and T. Utoro, “Endometrial Receptivity Defects MUC-1 and COX-2 Polymorphisms in Endometriosis,” Journal of Medicine and Life 16, no. 10 (2023): 1503–1507. - 10S. Cho, S. H. Park, Y. S. Choi, et al., “Expression of Cyclooxygenase-2 in Eutopic Endometrium and Ovarian Endometriotic Tissue in Women With Severe Endometriosis,” Gynecologic and Obstetric Investigation 69, no. 2 (2010): 93–100. - 11S. E. Bulun, Z. Lin, G. Imir, et al., “Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment,” Pharmacological Reviews 57, no. 3 (2005): 359–383. - 12L. H. Chen, W. C. Lo, H. Y. Huang, and H. M. Wu, “A Lifelong Impact on Endometriosis: Pathophysiology and Pharmacological Treatment,” International Journal of Molecular Sciences 24, no. 8 (2023): 7503. - 13D. Szukiewicz, “Insight Into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis,” International Journal of Molecular Sciences 24, no. 15 (2023): 12195. - 14R. Kiyama, “Estrogenic Flavonoids and Their Molecular Mechanisms of Action,” Journal of Nutritional Biochemistry 114 (2023): 109250. - 15A. L. Ososki and E. J. Kennelly, “Phytoestrogens: A Review of the Present State of Research,” Phytotherapy Research 17, no. 8 (2003): 845–869. - 16S. Youseflu, S. H. Jahanian Sadatmahalleh, A. Mottaghi, and A. Kazemnejad, “Dietary Phytoestrogen Intake and the Risk of Endometriosis in Iranian Women: A Case-Control Study,” International Journal of Fertility & Sterility 13, no. 4 (2020): 296–300. - 17T. M. Gruber and S. Mechsner, “Pathogenesis of Endometriosis: The Origin of Pain and Subfertility,” Cells 10, no. 6 (2021): 1381. - 18P. R. Koninckx, A. Ussia, L. Adamyan, A. Wattiez, V. Gomel, and D. C. Martin, “Pathogenesis of Endometriosis: The Genetic /Epigenetic Theory,” Fertility and Sterility 111, no. 2 (2019): 327–340. - 19E. Chantalat, M. C. Valera, C. Vaysse, et al., “Estrogen Receptors and Endometriosis,” International Journal of Molecular Sciences 21, no. 8 (2020): 2815. - 20T. Mori, F. Ito, A. Koshiba, et al., “Local Estrogen Formation and Its Regulation in Endometriosis,” Reproductive Medicine and Biology 18, no. 4 (2019): 305–311. - 21K. Huhtinen, R. Desai, M. Ståhle, et al., “Endometrial and Endometriotic Concentrations of Estrone and Estradiol Are Determined by Local Metabolism Rather Than Circulating Levels,” Journal of Clinical Endocrinology and Metabolism 97, no. 11 (2012): 4228–4235. - 22Z. R. Tang, R. Zhang, Z. X. Lian, S. L. Deng, and K. Yu, “Estrogen-Receptor Expression and Function in Female Reproductive Disease,” Cells 8, no. 10 (2019): 1123. - 23K. J. Berkley, A. J. Rapkin, and R. E. Papka, “The Pains of Endometriosis,” Science 308, no. 5728 (2005): 1587–1589. - 24G. Márki, A. Bokor, J. Rigó, and A. Rigó, “Physical Pain and Emotion Regulation as the Main Predictive Factors of Health-Related Quality of Life in Women Living With Endometriosis,” Human Reproduction 32, no. 7 (2017): 1432–1438. - 25W. Zheng, L. Cao, Z. Xu, Y. Ma, and X. Liang, “Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms,” Evidence-Based Complementary and Alternative Medicine 2018 (2018): 4128984. - 26E. Attar and S. E. Bulun, “Aromatase and Other Steroidogenic Genes in Endometriosis: Translational Aspects,” Human Reproduction Update 12, no. 1 (2006): 49–56. - 27H. Maia, Jr., J. Casoy, and J. Valente Filho, “Is Aromatase Expression in the Endometrium the Cause of Endometriosis and Related Infertility?,” Gynecological Endocrinology 25, no. 4 (2009): 253–257. - 28S. W. Guo, “Nuclear Factor-Kappab (NF-kappaB): An Unsuspected Major Culprit in the Pathogenesis of Endometriosis That Is Still at Large?,” Gynecologic and Obstetric Investigation 63, no. 2 (2007): 71–97. - 29Z. Z. Lai, H. L. Yang, S. Y. Ha, et al., “Cyclooxygenase-2 in Endometriosis,” International Journal of Biological Sciences 15, no. 13 (2019): 2783–2797. - 30Y. Sakamoto, T. Harada, S. Horie, et al., “Tumor Necrosis Factor-Alpha-Induced Interleukin-8 (IL-8) Expression in Endometriotic Stromal Cells, Probably Through Nuclear Factor-Kappa B Activation: Gonadotropin-Releasing Hormone Agonist Treatment Reduced IL-8 Expression,” Journal of Clinical Endocrinology and Metabolism 88, no. 2 (2003): 730–735. - 31A. M. Dull, M. A. Moga, O. G. Dimienescu, G. Sechel, V. Burtea, and C. V. Anastasiu, “Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways,” Molecules 24, no. 4 (2019): 667. - 32M. C. Canivenc-Lavier and C. Bennetau-Pelissero, “Phytoestrogens and Health Effects,” Nutrients 15, no. 2 (2023): 317. - 33M. Khodarahmian, F. Amidi, A. Moini, et al., “A Randomized Exploratory Trial to Assess the Effects of Resveratrol on VEGF and TNF-α 2 Expression in Endometriosis Women,” Journal of Reproductive Immunology 143 (2021): 103248. - 34S. H. Ahn, S. P. Monsanto, C. Miller, S. S. Singh, R. Thomas, and C. Tayade, “Pathophysiology and Immune Dysfunction in Endometriosis,” BioMed Research International 2015 (2015): 795976. - 35R. Kolahdouz-Mohammadi, F. Shidfar, S. Khodaverdi, et al., “Resveratrol Treatment Reduces Expression of MCP-1, IL-6, IL-8 and RANTES in Endometriotic Stromal Cells,” Journal of Cellular and Molecular Medicine 25, no. 2 (2021): 1116–1127. - 36C. Wang, Z. Chen, X. Zhao, et al., “Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in a Rat Model,” Drug Design, Development and Therapy 15 (2021): 4141–4155. - 37D. da Mendes Silva, L. A. Gross, E. P. G. Neto, B. A. Lessey, and R. F. Savaris, “The Use of Resveratrol as an Adjuvant Treatment of Pain in Endometriosis: A Randomized Clinical Trial,” Journal of the Endocrine Society 1, no. 4 (2017): 359–369. - 38R. T. Mankowski, L. You, T. W. Buford, et al., “Higher Dose of Resveratrol Elevated Cardiovascular Disease Risk Biomarker Levels in Overweight Older Adults—A Pilot Study,” Experimental Gerontology 131 (2020): 110821. - 39A. Carrizzo, M. Forte, A. Damato, et al., “Antioxidant Effects of Resveratrol in Cardiovascular, Cerebral and Metabolic Diseases,” Food and Chemical Toxicology 61 (2013): 215–226. - 40H. J. Chan, K. Petrossian, and S. Chen, “Structural and Functional Characterization of Aromatase, Estrogen Receptor, and Their Genes in Endocrine-Responsive and -Resistant Breast Cancer Cells,” Journal of Steroid Biochemistry and Molecular Biology 161 (2016): 73–83. - 41J. Tomé-Carneiro, M. Larrosa, A. González-Sarrías, F. A. Tomás-Barberán, M. T. García-Conesa, and J. C. Espín, “Resveratrol and Clinical Trials: The Crossroad From In Vitro Studies to Human Evidence,” Current Pharmaceutical Design 19, no. 34 (2013): 6064–6093. - 42K. K. Rocha, G. A. Souza, G. X. Ebaid, F. R. Seiva, A. C. Cataneo, and E. L. Novelli, “Resveratrol Toxicity: Effects on Risk Factors for Atherosclerosis and Hepatic Oxidative Stress in Standard and High-Fat Diets,” Food and Chemical Toxicology 47, no. 6 (2009): 1362–1367. - 43V. A. Brown, K. R. Patel, M. Viskaduraki, et al., “Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-Like Growth Factor Axis,” Cancer Research 70, no. 22 (2010): 9003–9011. - 44S. Hüser, S. Guth, H. G. Joost, et al., “Effects of Isoflavones on Breast Tissue and the Thyroid Hormone System in Humans: A Comprehensive Safety Evaluation,” Archives of Toxicology 92, no. 9 (2018): 2703–2748. - 45H. M. Ho, R. Y. Chen, L. K. Leung, F. L. Chan, Y. Huang, and Z. Y. Chen, “Difference in Flavonoid and Isoflavone Profile Between Soybean and Soy Leaf,” Biomedicine & Pharmacotherapy 56, no. 6 (2002): 289–295. - 46A. Micek, J. Godos, T. Brzostek, et al., “Dietary Phytoestrogens and Biomarkers of Their Intake in Relation to Cancer Survival and Recurrence: A Comprehensive Systematic Review With Meta-Analysis,” Nutrition Reviews 79, no. 1 (2021): 42–65. - 47S. B. Bhyan, L. Zhao, Y. Wee, Y. Liu, and M. Zhao, “Genetic Links Between Endometriosis and Cancers in Women,” PeerJ 7 (2019): e8135. - 48J. A. López-Velázquez, L. D. Carrillo-Córdova, N. C. Chávez-Tapia, M. Uribe, and N. Méndez-Sánchez, “Nuclear Receptors in Nonalcoholic Fatty Liver Disease,” Journal of Lipids 2012 (2012): 139875. - 49A. G. Ricci, C. N. Olivares, M. A. Bilotas, et al., “Natural Therapies Assessment for the Treatment of Endometriosis,” Human Reproduction 28, no. 1 (2013): 178–188. - 50M. R. Khazaei, Z. Rashidi, F. Chobsaz, E. Niromand, and M. Khazaei, “Inhibitory Effect of Resveratrol on the Growth and Angiogenesis of Human Endometrial Tissue in an In Vitro Three-Dimensional Model of Endometriosis,” Reproductive Biology 20, no. 4 (2020): 484–490. - 51M. Ji, Y. Liu, S. Yang, et al., “Puerarin Suppresses Proliferation of Endometriotic Stromal Cells in Part via Differential Recruitment of Nuclear Receptor Coregulators to Estrogen Receptor-α,” Journal of Steroid Biochemistry and Molecular Biology 138 (2013): 421–426. - 52O. Takaoka, T. Mori, F. Ito, et al., “Daidzein-Rich Isoflavone Aglycones Inhibit Cell Growth and Inflammation in Endometriosis,” Journal of Steroid Biochemistry and Molecular Biology 181 (2018): 125–132. - 53M. T. Viggiani, L. Polimeno, A. Di Leo, and M. Barone, “Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms Against Colorectal Neoproliferative Lesions,” Nutrients 11, no. 8 (2019): 1709. - 54K. D. Setchell, N. M. Brown, P. Desai, et al., “Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements,” Journal of Nutrition 131, no. 4 Suppl (2001): 1362s–1375s. - 55D. Kostelac, G. Rechkemmer, and K. Briviba, “Phytoestrogens Modulate Binding Response of Estrogen Receptors Alpha and Beta to the Estrogen Response Element,” Journal of Agricultural and Food Chemistry 51, no. 26 (2003): 7632–7635. - 56A. Rauf, M. Imran, M. S. Butt, M. Nadeem, D. G. Peters, and M. S. Mubarak, “Resveratrol as an Anti-Cancer Agent: A Review,” Critical Reviews in Food Science and Nutrition 58, no. 9 (2018): 1428–1447. - 57R. Nakata, S. Takahashi, and H. Inoue, “Recent Advances in the Study on Resveratrol,” Biological & Pharmaceutical Bulletin 35, no. 3 (2012): 273–279. - 58I. N. A. Azam, N. A. Wahab, M. H. Mokhtar, M. N. Shafiee, and N. M. Mokhtar, “Roles of microRNAs in Regulating Apoptosis in the Pathogenesis of Endometriosis,” Life (Basel) 12, no. 9 (2022): 1321. - 59N. Kim, J. Kwon, U. S. Shin, and J. Jung, “Stimulatory Anticancer Effect of Resveratrol Mediated by G Protein-Coupled Estrogen Receptor in Colorectal Cancer,” Biomolecules & Therapeutics (Seoul) 31, no. 6 (2023): 655–660. - 60G. Yerlikaya, S. Balendran, K. Pröstling, et al., “Comprehensive Study of Angiogenic Factors in Women With Endometriosis Compared to Women Without Endometriosis,” European Journal of Obstetrics, Gynecology, and Reproductive Biology 204 (2016): 88–98. - 61A. S. Chung and N. Ferrara, “Developmental and Pathological Angiogenesis,” Annual Review of Cell and Developmental Biology 27 (2011): 563–584. - 62M. J. Ronis, H. Gomez-Acevedo, M. L. Blackburn, M. A. Cleves, R. Singhal, and T. M. Badger, “Uterine Responses to Feeding Soy Protein Isolate and Treatment With 17β-Estradiol Differ in Ovariectomized Female Rats,” Toxicology and Applied Pharmacology 297 (2016): 68–80. - 63I. Kang, C. H. Rim, H. S. Yang, J. S. Choe, J. Y. Kim, and M. Lee, “Effect of Isoflavone Supplementation on Menopausal Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” Nutrition Research and Practice 16, no. Suppl 1 (2022): S147–S159. - 64G. D'Arrigo, E. Gianquinto, G. Rossetti, G. Cruciani, S. Lorenzetti, and F. Spyrakis, “Binding of Androgen- and Estrogen-Like Flavonoids to Their Cognate (Non)nuclear Receptors: A Comparison by Computational Prediction,” Molecules 26, no. 6 (2021): 1613. - 65E. Yavuz, M. Oktem, I. Esinler, S. A. Toru, and H. B. Zeyneloglu, “Genistein Causes Regression of Endometriotic Implants in the Rat Model,” Fertility and Sterility 88, no. 4 Suppl (2007): 1129–1134. - 66A. Gołąbek, K. Kowalska, and A. Olejnik, “Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives,” Nutrients 13, no. 4 (2021): 1347. - 67Z. R. Du, Y. Gu, X. M. Xie, M. Zhang, G. Y. Jiang, and W. F. Chen, “GPER and IGF-1R Mediate the Anti-Inflammatory Effect of Genistein Against Lipopolysaccharide (LPS)-Induced Nigrostriatal Injury in Rats,” Journal of Steroid Biochemistry and Molecular Biology 214 (2021): 105989. - 68M. Tsuchiya, T. Miura, T. Hanaoka, et al., “Effect of Soy Isoflavones on Endometriosis: Interaction With Estrogen Receptor 2 Gene Polymorphism,” Epidemiology 18, no. 3 (2007): 402–408. - 69S. S. Zhang, J. Y. Duan, T. T. Zhang, M. Lv, and X. G. Gao, “Effect of Compound Dietary Fiber of Soybean Hulls on the Gel Properties of Myofibrillar Protein and Its Mechanism in Recombinant Meat Products,” Frontiers in Nutrition 10 (2023): 1129514. - 70W. L. Hall, K. Vafeiadou, J. Hallund, et al., “Soy-Isoflavone-Enriched Foods and Markers of Lipid and Glucose Metabolism in Postmenopausal Women: Interactions With Genotype and Equol Production,” American Journal of Clinical Nutrition 83, no. 3 (2006): 592–600. - 71M. Li and C. Eastman, “The Changing Epidemiology of Iodine Deficiency,” Nature Reviews Endocrinology 8 (2012): 434–440. - 72A. C. Soni, M. B. Conroy, R. H. Mackey, and L. H. Kuller, “Ghrelin, Leptin, Adiponectin, and Insulin Levels and Concurrent and Future Weight Change in Overweight, Postmenopausal Women,” Menopause 18, no. 3 (2011): 296–301. - 73M. Reyes-Farias and C. Carrasco-Pozo, “The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism,” International Journal of Molecular Sciences 20, no. 13 (2019): 3177. - 74Y. Cao, M. F. Zhuang, Y. Yang, et al., “Preliminary Study of Quercetin Affecting the Hypothalamic-Pituitary-Gonadal Axis on Rat Endometriosis Model,” Evidence-Based Complementary and Alternative Medicine 2014 (2014): 781684. - 75N. Jamali, F. Zal, Z. Mostafavi-Pour, M. Samare-Najaf, T. Poordast, and A. Dehghanian, “Ameliorative Effects of Quercetin and Metformin and Their Combination Against Experimental Endometriosis in Rats,” Reproductive Sciences 28, no. 3 (2021): 683–692. - 76L. Zhang, K. Mohankumar, G. Martin, et al., “Flavonoids Quercetin and Kaempferol Are NR4A1 Antagonists and Suppress Endometriosis in Female Mice,” Endocrinology 164, no. 10 (2023): bqad133. - 77B. Salehi, A. Venditti, M. Sharifi-Rad, et al., “The Therapeutic Potential of Apigenin,” International Journal of Molecular Sciences 20, no. 6 (2019): 1305. - 78C. Yang, J. Song, S. Hwang, J. Choi, G. Song, and W. Lim, “Apigenin Enhances Apoptosis Induction by 5-Fluorouracil Through Regulation of Thymidylate Synthase in Colorectal Cancer Cells,” Redox Biology 47 (2021): 102144. - 79Z. Fabová, Z. Kislíková, B. Loncová, M. Bauer, A. H. Harrath, and A. V. Sirotkin, “MicroRNA miR-152 Can Support Ovarian Granulosa Cell Functions and Modify Apigenin Actions,” Domestic Animal Endocrinology 84-85 (2023): 106805. - 80A. Sirotkin, Z. Záhoranska, A. Tarko, Z. Fabova, S. Alwasel, and A. Halim Harrath, “Plant Polyphenols Can Directly Affect Ovarian Cell Functions and Modify Toluene Effects,” Journal of Animal Physiology and Animal Nutrition (Berlin) 105, no. 1 (2021): 80–89. - 81K. S. Allemailem, A. Almatroudi, H. O. A. Alharbi, et al., “Apigenin: A Bioflavonoid With a Promising Role in Disease Prevention and Treatment,” Biomedicine 12, no. 6 (2024): 1353. - 82Y. O. Kim, K. Leem, J. Park, et al., “Cytoprotective Effect of Scutellaria baicalensis in CA1 Hippocampal Neurons of Rats After Global Cerebral Ischemia,” Journal of Ethnopharmacology 77, no. 2–3 (2001): 183–188. - 83Z. Jin, J. Huang, and Z. Zhu, “Baicalein Reduces Endometriosis by Suppressing the Viability of Human Endometrial Stromal Cells Through the Nuclear Factor-κB Pathway In Vitro,” Experimental and Therapeutic Medicine 14, no. 4 (2017): 2992–2998. - 84H. Liu, Y. Dong, Y. Gao, et al., “The Fascinating Effects of Baicalein on Cancer: A Review,” International Journal of Molecular Sciences 17, no. 10 (2016): 1681. - 85L. S. Po, Z. Y. Chen, D. S. Tsang, and L. K. Leung, “Baicalein and Genistein Display Differential Actions on Estrogen Receptor (ER) Transactivation and Apoptosis in MCF-7 Cells,” Cancer Letters 187, no. 1–2 (2002): 33–40. - 86J. Y. Ke, J. Yang, J. Li, Z. Xu, M. Q. Li, and Z. L. Zhu, “Baicalein Inhibits FURIN-MT1-MMP-Mediated Invasion of Ectopic Endometrial Stromal Cells in Endometriosis Possibly by Reducing the Secretion of TGFB1,” American Journal of Reproductive Immunology 85, no. 3 (2021): e13344. - 87W. Park, H. Jang, H. S. Kim, et al., “Therapeutic Efficacy and Anti-Inflammatory Mechanism of Baicalein on Endometriosis Progression in Patient-Derived Cell Line and Mouse Model,” Phytomedicine 130 (2024): 155469. - 88R. R. Kotha and D. L. Luthria, “Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects,” Molecules 24, no. 16 (2019): 2930. - 89I. Chowdhury, S. Banerjee, A. Driss, et al., “Curcumin Attenuates Proangiogenic and Proinflammatory Factors in Human Eutopic Endometrial Stromal Cells Through the NF-κB Signaling Pathway,” Journal of Cellular Physiology 234, no. 5 (2019): 6298–6312. - 90J. Ding, S. Mei, K. Wang, et al., “Curcumin Modulates Oxidative Stress to Inhibit Pyroptosis and Improve the Inflammatory Microenvironment to Treat Endometriosis,” Genes & Diseases 11, no. 3 (2024): 101053. - 91P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, “Bioavailability of Curcumin: Problems and Promises,” Molecular Pharmaceutics 4, no. 6 (2007): 807–818. - 92M. Sun, X. Su, B. Ding, et al., “Advances in Nanotechnology-Based Delivery Systems for Curcumin,” Nanomedicine (London, England) 7, no. 7 (2012): 1085–1100. - 93S. A. Wright, F. M. O'Prey, M. T. McHenry, et al., “A Randomised Interventional Trial of Omega-3-Polyunsaturated Fatty Acids on Endothelial Function and Disease Activity in Systemic Lupus Erythematosus,” Annals of the Rheumatic Diseases 67, no. 6 (2008): 841–848. Article Metrics Total unique accesses to an article’s full text in HTML or PDF/ePDF format.More metric information Scite metrics Explore this article's citation statements on scite.ai Share QR Code Generating QR code QR code copied to clipboard! Something went wrong while generating your QR code. Please try again in a moment. If the issue persists, refresh the page or contact support. Export citation Unable to load citation data. Please try again in a moment. How to cite Elkins, L. J., & Spiegelman, M. (2021). pyUserCalc: A revised Jupyter notebook calculator for uranium-series disequilibria in basalts. Earth and Space Science, 8, e2020EA001619. https://doi.org/10.1029/2020EA001619 Download Citation If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click on download. This feature enables you to download the bibliographic information (also called citation data, header data, or metadata) for the articles on our site. Citation manager file format Use the dropdown list to choose how to format the bibliographic data you're harvesting. Several citation manager formats are available, including EndNote and BibTex. You can then copy the formatted citation (as displayed) or download it as file, to your device. If the RefWorks format is chosen, the 'Download' button will be replaced with an option to directly export to RefWorks